insights_auto
Why is PRQR down 3.51%?
Dive Deeperchevron_right
PRQR:NASDAQ
ProQR Therapeutics NV
$1.65
arrow_downward
-3.51%(-0.060) 1D
$1.66
arrow_upward
+0.60% (+0.0099)bedtimeAfter hours
Closed: Sep 25, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PRQR...
Open
$1.72
High
$1.72
Low
$1.63
Mkt. cap
232.85M
Avg. vol.
814.93K
Volume
584.82K
52-wk high
$3.10
52-wk low
$1.34
EPS
-$0.45
Beta
0.06
Shares outstanding
138.09M
No. of employees
187
Open
$1.72
High
$1.72
Low
$1.63
Mkt. cap
232.85M
Avg. vol.
814.93K
Volume
584.82K
52-wk high
$3.10
52-wk low
$1.34
EPS
-$0.45
Beta
0.06
Shares outstanding
138.09M
No. of employees
187
News stories
From web sources and news partners
TipRanks
·
2 days ago
ProQR Taps AI Leaders Chris Hart and Thomas Wolf to Accelerate Axiomer RNA Editing Pipeline
Investing.com
·
2 days ago
ProQR names AI executives as clinical data nears
Stock Titan
·
2 days ago
Hugging Face co-founder joins ProQR (PRQR) to drive AI drug discovery
Profile
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia
About ProQR Therapeutics NV